The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers
Authors
Keywords
Connexin43, miR-125b, p53, Breast cancer
Journal
CELLULAR ONCOLOGY
Volume 38, Issue 6, Pages 443-451
Publisher
Springer Nature
Online
2015-09-02
DOI
10.1007/s13402-015-0240-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pathological Implications of Cx43 Down-regulation in Human Colon Cancer
- (2014) Rehana Ismail et al. Asian Pacific Journal of Cancer Prevention
- MicroRNAs and human diseases: diagnostic and therapeutic potential
- (2014) Raihana Maqbool et al. CELL AND TISSUE RESEARCH
- Good guy or bad guy: the opposing roles of microRNA 125b in cancer
- (2014) Julia Banzhaf-Strathmann et al. Cell Communication and Signaling
- Internal Ribosomal Entry Site (IRES) Activity Generates Endogenous Carboxyl-terminal Domains of Cx43 and Is Responsive to Hypoxic Conditions
- (2014) Mahboob Ul-Hussain et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The chemosensitivity of testicular germ cell tumors
- (2014) Ioannis A. Voutsadakis CELLULAR ONCOLOGY
- The cancer genome: from structure to function
- (2014) Ad Geurts van Kessel CELLULAR ONCOLOGY
- Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status
- (2014) Lene Rask et al. CELLULAR ONCOLOGY
- A novel saliva-based microRNA biomarker panel to detect head and neck cancers
- (2014) Carolina Salazar et al. CELLULAR ONCOLOGY
- MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways
- (2013) N Wu et al. BRITISH JOURNAL OF CANCER
- miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-α, CCNJ, and MEGF9
- (2013) Andrea Feliciano et al. PLoS One
- P53 protein in proliferation, repair and apoptosis of cells
- (2013) Ewelina Wawryk-Gawda et al. PROTOPLASMA
- miRNAs in head and neck cancer revisited
- (2013) Rahul Nagadia et al. CELLULAR ONCOLOGY
- MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma
- (2013) Yuanyuan Wang et al. CELLULAR ONCOLOGY
- Thymidylate synthase expression and p21WAF1/p53 phenotype of colon cancers identify patients who may benefit from 5-fluorouracil based therapy
- (2013) Violetta Sulzyc-Bielicka et al. CELLULAR ONCOLOGY
- Micro-RNAs (miRNAs): genomic organisation, biogenesis and mode of action
- (2012) Mahboob Ul Hussain CELL AND TISSUE RESEARCH
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome
- (2011) Solveig Sirnes et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search